Company / Total Assets
Day One Biopharmaceuticals, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$507.8M
FY2025
5-year range
$289.8M / $582.8M
FY2021-FY2025
Trend
-12.9%
vs FY2024
Sector context
#140 of 216
Health Care
What the data says
At $508M, Day One Biopharmaceuticals, Inc.'s total assets ranks #140 of 216 in the Health Care sector. Improved from $376M to $508M over the past 2 years.
Based on SEC 10-K filings.
$508M in FY2025 with a 5-year CAGR of +61.9%.
Improved from $376M to $508M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- +61.9%
- 10-Year CAGR
- -
Sector benchmark
#140 of 216 in Health CareTop 65% of 216This company $507.8M Sector average $7.4B
▼
-93.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +61.9%, indicating consistent growth.
- In FY2025, total assets decreased 12.9% year-over-year.
- Ranks #140 out of 216 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $507.8M | -12.9% |
| FY2024 | $582.8M | +55.0% |
| FY2023 | $376.0M | +7.7% |
| FY2022 | $349.1M | +20.4% |
| FY2021 | $289.8M | +534.7% |
| FY2020 | $45.7M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026